tradingkey.logo

Achieve Life Sciences Inc <ACHV.OQ> expected to post a loss of 32 cents a share - Earnings Preview

ReutersMar 7, 2025 1:22 PM
  • Achieve Life Sciences Inc ACHV.OQ ACHV.O is expected to show no change in quarterly revenue when it reports results on March 11 for the period ending December 31 2024

  • ​LSEG's mean analyst estimate for Achieve Life Sciences Inc is for a loss of 32 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Achieve Life Sciences Inc is $16.00​, above​ its last closing price of $3.14. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.28

-0.26

-0.36

Missed

-37.7

Jun. 30 2024

-0.23

-0.23

-0.25

Missed

-7.9

Mar. 31 2024

-0.25

-0.24

-0.26

Missed

-6.6​

Dec. 31 2023

-0.31

-0.31

-0.26

Beat

17.3

​​Sep. 30 2023

-0.37

-0.38

-0.34

Beat

10.2

Jun. 30 2023

-0.41

-0.42

-0.43

Missed

-2​

Mar. 31 2023

-0.68

-0.69

-0.50

Beat

27.1

Dec. 31 2022

-0.77

-0.83

-0.83

Met

0

This summary was machine generated March 7 at 13:22 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI